JAKARTA – For more than three decades, Dexa Group has consistently contributed to providing quality medicines for the Indonesian people through Obat Generik Berlogo/OGB (unbranded generics) Dexa. Today, OGB Dexa produces more than 2 billion units annually with over 140 SKUs to support the National Health Insurance (JKN) program.
This contribution to ensuring the availability of quality and affordable medicines has been ongoing since production began in 1991. In 1991, Dexa Medica became the first private pharmaceutical company in Indonesia to produce OGB. This commitment has been continuously reinforced alongside government initiatives, ranging from Health Insurance (Askes) in 2005 to the National Health Insurance (JKN) program in 2014.
“Generic medicines play a crucial role in expanding public access to quality and affordable healthcare. Therefore, we continuously maintain product quality, expand production capacity, and ensure the availability of OGB to support national healthcare needs,” stated Mr. Jopie Johansyah, Sales Director of OGB Zeta at PT Dexa Medica.
In terms of branding, OGB Dexa features signature red packaging, making it easily recognizable as a logo-branded generic medicine. Product quality remains a top priority, supported by compliance with relevant standards and certifications. OGB Dexa has also earned Halal certification as part of the company’s commitment to providing products that meet public needs and offer peace of mind.
More than three decades of consistency have helped build OGB Dexa’s strong reputation in the Indonesian generic medicine market. Backed by high production capacity, a portfolio of over 140 SKUs across various therapeutic areas for JKN, and an unwavering commitment to quality, OGB Dexa continues to play an active role in supporting public access to medicine while driving the sustainability of the national health program.
This ongoing contribution reflects Dexa Group’s journey as a resilient, adaptive, and growing organization that leverages its expertise for health, delivering products that reach and serve the broader needs of the Indonesian public.